The Greek Research Infrastructure for Personalised Μedicine
Towards more accurate and cost-effective health management for the Greek citizen
Strengthen basic research
Harness the “big data” revolution
Revise clinical trial designs
Move regulatory science forward
Enhance patient access to innovative medicines
A specialized regional
Pharmaceutical R&D departments
Biotechnology SMEs and diagnostics developers
Biomedical and clinical researchers
National and European biomedical research infrastructures
Patients and patient foundations
pMedGR aims at supporting research and innovation towards next generation healthcare applications. Specifically, the infrastructure aims at re-designing ongoing and prospective clinical trials, linking them with molecular profiles obtained through high-throughput ‘omics’ technologies towards more efficient and cost-effective health and disease management for European citizens.
pMedGR offers a unique opportunity for obtaining real added value for the European and regional social market economy and has a high potential for attracting private investments, maximizing synergies between national and EU funding schemes and thus mobilizing, leveraging and bundling different types of public and private funding. It combines economic viability with high-socioeconomic returns in the area of healthcare management and brings together the industrial sector, clinicians, medical researchers, biomedical scientists and technology experts, thus providing the necessary means to initiate and develop innovation.
News & Events
pMedGR announces a position call for 3 BioScientists (2 at PhD and 1 at MSc level), 1 BioInformatician (PhD level) and 3 BioScientists (PhD or MD level).
Application Deadline: 16/07/2018.
The 1st Scientific Workshop of the Centre of New Biotechnologies and Precision Medicine (CNBPM) of the Medical School of the National & Kapodistrian University of Athens (NKUA) & of the Greek Research Infrastructure for Personalised Medicine (pMedGR) took place at the Medical Scool's Auditorium «G. Kotzias».